Primary Immune Deficiency in Geriatric Patients


Want a discount? Become a member by purchasing Corporate Membership, Enterprise Corporate Membership or Individual Membership!



Jointly provided by Partners for Advancing Clinical Education (PACE) and Ig National Society, Inc.

Original Release Date: February 2021
Last Review Date: January 2024
Expiration Date: January 2025

Speaker: Roger H. Kobayashi, MD

Continuing Education: Nursing 1.0 contact hour | Pharmacy 1.0 contact hour |  Physician 1.0 AMA PRA Category 1 Credit(s)™

Recertification: 1 IgCN® / IgCP® Recertification Units

Target Audience

This activity is intended for physicians, nurses, pharmacists, and other healthcare professionals who care for patients in need of immunoglobulin therapy and specialty biologics.

Educational Objectives                                                   

Upon completion of this activity, participants should be able to:

  • Recognize that PID is not rare in the geriatric age group and maybe difficult to diagnose and be able to define the aging population
  • Recognize that aging normally causes deterioration and loss of immune functions
  • Discuss the demographic and geographic trends of aging population
  • Describe the considerations of Ig therapy in regards to dosing, routes of administration, adverse reactions and other risks in geriatric patients
  • Recognize the collaborative practice model to provide optimal patient care